| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.68B | 62.74B | 58.56B | 52.98B | 51.62B | 52.65B |
| Gross Profit | 66.65B | 60.70B | 56.55B | 52.01B | 51.45B | 52.23B |
| EBITDA | 8.34B | 11.48B | 11.53B | 11.42B | 11.12B | 6.66B |
| Net Income | 6.29B | 5.75B | 5.65B | 5.90B | 5.59B | 2.58B |
Balance Sheet | ||||||
| Total Assets | 3.11T | 2.98T | 3.07T | 3.04T | 3.06T | 2.78T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 171.57B | 341.75B | 598.66B | 770.55B | 525.14B |
| Total Debt | 18.82B | 19.54B | 82.95B | 104.86B | 585.72B | 130.09B |
| Total Liabilities | 2.97T | 2.84T | 2.92T | 2.90T | 2.93T | 2.65T |
| Stockholders Equity | 143.54B | 139.83B | 142.56B | 138.16B | 135.02B | 131.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.89B | 0.00 | -56.59B | 282.68B | 0.00 |
| Operating Cash Flow | 0.00 | 26.36B | 0.00 | -52.27B | 22.56B | 0.00 |
| Investing Cash Flow | 0.00 | -113.69B | -265.72B | -116.73B | -38.66B | -74.70B |
| Financing Cash Flow | 0.00 | -83.19B | 10.93B | -2.90B | 116.82B | -1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥119.10B | 8.48 | ― | 2.71% | 15.37% | 35.08% | |
75 Outperform | ¥98.45B | 1.54 | ― | 3.05% | 8.75% | -12.68% | |
72 Outperform | ¥150.42B | 8.04 | 3.68% | 2.26% | 9.34% | 20.61% | |
72 Outperform | ¥163.14B | 7.55 | ― | 2.29% | 13.93% | 54.44% | |
69 Neutral | ¥100.62B | 6.66 | ― | 2.46% | 9.12% | 43.43% | |
68 Neutral | ¥82.38B | 7.94 | ― | 2.29% | 7.97% | 20.44% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |